Aims: Down Syndrome (DS), a genetic disease caused by a triplication of chromosome 21, is characterized by increased markers of oxidative stress. In addition to cognitive defects, patients with DS also display hematologic disorders and increased incidence of infections and leukemia. Using the Ts65Dn mouse model of DS, the goal of this study was to examine hematopoietic stem and lymphoid progenitor cell function in DS. Results: Analysis of hematopoietic progenitor populations showed that Ts65Dn mice possessed fewer functional hematopoietic stem cells and a significantly decreased percentage of bone marrow lymphoid progenitors. Increased reactive oxygen species and markers of oxidative stress were detected in hematopoietic stem cell populations and were associated with a loss of quiescence. Bone marrow progenitor populations expressed diminished levels of the IL-7R alpha chain, which was associated with decreased proliferation and increased apoptosis. Modulating oxidative stress in vitro suggested that oxidative stress selectively leads to decreased IL-7R alpha expression, and inhibits the survival of IL-7R alpha-expressing hematopoietic progenitors, potentially linking increased reactive oxygen species and immunopathology. Innovation: The study results identify a link between oxidative stress and diminished IL-7R alpha expression and function. Further, the data suggest that this decrease in IL-7R alpha is associated with defective hematopoietic development in Down Syndrome. Conclusion: The data suggest that hematopoietic stem and lymphoid progenitor cell defects underlie immune dysfunction in DS and that increased oxidative stress and reduced cytokine signaling may alter hematologic development in Ts65Dn mice. Antioxid. Redox Signal. 15, 2083-2094.
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
Cochrane, Shawn W.
Zhao, Ying
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
Zhao, Ying
Welner, Robert S.
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
Welner, Robert S.
Sun, Xiao-Hong
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
Cochrane, Shawn W.
Zhao, Ying
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
Zhao, Ying
Welner, Robert S.
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA
Welner, Robert S.
Sun, Xiao-Hong
论文数: 0引用数: 0
h-index: 0
机构:
Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USAOklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA